QuantalX Neuroscience

QuantalX Neuroscience manufactures Delphi-MD™, a non-invasive brain network function assessment device using Direct Electrophysiological Imaging technology to map real-time brain activity. The device captures transcranial magnetic stimulation (TMS)-evoked brain potentials (TEPs) and provides quantitative output parameters compared against a normative reference database for ages 50–75. Unlike conventional neuroimaging, Delphi-MD™ operates in any care setting—clinics, hospitals, research facilities—without radiation exposure. The system is indicated for brain health assessment, neurology, psychiatry, and research applications. FDA De Novo cleared, the device generates comprehensive, age-correlated results reports integrated into clinical workflows. Key features include rapid assessment, radiation-free operation, proven validation through peer-reviewed publications, and cost-effectiveness. Clinical interpretations must be made by qualified healthcare professionals within full patient evaluation context. Potential adverse events include headache, nausea, dizziness, fatigue, insomnia, anxiety, back/neck pain, vomiting, tinnitus, migraine aura, and abnormal sensations. The device is not intended as a sole diagnostic tool. Serves providers, researchers, and institutional buyers seeking objective, accessible brain function measurement.